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Edited by Takashi GojoboriAbstract One of the main objectives in the analysis of
microarray experiments is the identiﬁcation of genes that are
diﬀerentially expressed under two experimental conditions. This
task is complicated by the noisiness of the data and the large
number of genes that are examined simultaneously. Here, we
present a novel technique for identifying diﬀerentially expressed
genes that does not originate from a sophisticated statistical
model but rather from an analysis of biological reasoning. The
new technique, which is based on calculating rank products (RP)
from replicate experiments, is fast and simple. At the same time,
it provides a straightforward and statistically stringent way to
determine the signiﬁcance level for each gene and allows for the
ﬂexible control of the false-detection rate and familywise error
rate in the multiple testing situation of a microarray experiment.
We use the RP technique on three biological data sets and show
that in each case it performs more reliably and consistently than
the non-parametric t-test variant implemented in Tusher et al.’s
signiﬁcance analysis of microarrays (SAM). We also show that
the RP results are reliable in highly noisy data. An analysis
of the physiological function of the identiﬁed genes indicates that
the RP approach is powerful for identifying biologically relevant
expression changes. In addition, using RP can lead to a sharp
reduction in the number of replicate experiments needed to
obtain reproducible results.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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DNA microarrays are a powerful technology for monitoring
the expression level of thousands of genes simultaneously.
They provide the basis for a variety of applications, including
tumor classiﬁcation, molecular pathway modeling, and func-q Supplementary data associated with this article can be found, in the
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doi:10.1016/j.febslet.2004.07.055tional genomics. One of the most popular uses, however, is the
comparison of gene expression diﬀerence under two distinct
experimental conditions (treated vs. untreated samples, dis-
eased vs. normal tissue, mutant vs. wild-type organisms, etc.).
In this kind of experimental setup, the main challenge is the
identiﬁcation of those genes whose expression is signiﬁcantly
diﬀerent between the two conditions. The earliest approach
used a simple fold-change (FC) criterion to detect genes of
interest [1], but this has the obvious disadvantage that it does
not provide a signiﬁcance estimate for the observed changes
and that the necessary cutoﬀ values (2-fold? 1.68-fold?) are
essentially arbitrary. Hence, replicated experiments and in-
creasingly sophisticated statistical tests were soon suggested to
achieve a more reliable identiﬁcation of diﬀerentially regulated
genes. While all of these techniques provide results that are
better justiﬁed than a crude FC heuristics, they have several
shortcomings. First of all, they lack the intuitive appeal of the
FC criterion. In many situations, it is unlikely that very small
fold-changes have any biological relevance even if they are
signiﬁcant statistically, for example when many other genes in
the same condition show much larger changes. Second, the
authors of the diﬀerent algorithms oﬀer little, if any, justiﬁ-
cation for their underlying error models. Indeed, modern
techniques which make relatively weak assumptions give more
robust results than a classical t-test that assumes normality of
the error, but they still in most cases assume a symmetrically
distributed error [2]. This assumption is clearly violated by the
biological variation in a number of the most common experi-
mental designs, e.g., in a tumor-versus-normal comparison
every tumor sample may contain some amount of normal
tissue, so that the real value of interest, i.e., the expression in a
pure tumor sample, lies well outside the measured values. The
third shortcoming of current statistical techniques is that the
reasons for their diﬀerences in performance are very little un-
derstood. Most current approaches use similar basic statistics
and diﬀer mainly in their determination of the signiﬁcance/
rejection level [2]. When applied to biological data (instead of
simulated data sets), they give very similar overall results [2–4],
but often show important and seemingly random diﬀerences
for some genes [2–4]. There is currently no convincing ratio-
nale for choosing between the diﬀerent approaches. The
problem is further aggravated by the statistical expertise nec-
essary to appreciate the diﬀerences between the various algo-
rithms. This has led to a widespread feeling among biologists
that the choice of statistical analysis is rather arbitrary andblished by Elsevier B.V. All rights reserved.
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serious concerns that have discouraged some biologists from
considering microarray analysis for their particular scientiﬁc
questions.
Here, we present a novel statistical technique derived from
biological reasoning to overcome some of these problems. Our
technique, which is explained in detail below, is based on the
calculation of rank products (RP), is statistically rigorous and
can be used to provide reliable signiﬁcance thresholds to dis-
tinguish signiﬁcantly regulated genes. The results and sim-
plicity of RP are surprisingly similar to fold-changes, but
overcome its most signiﬁcant limitations. In contrast to pre-
vious approaches, the assumptions made for our method are
relatively weak. We assume (1) that relevant expression
changes aﬀect only a minority of genes, (2) measurements are
independent between replicate arrays, (3) most changes are
independent of each other, and (4) measurement variance is
about equal for all genes. The latter is a biologically reasonable
assumption that can be met by a number of recent normali-
zation techniques [5–7], which are rapidly becoming a standard
in the ﬁeld, independent of the analysis method used. As-
sumption (1) may look relatively restrictive, as it is easy to
imagine experimental setups where a majority of genes are
diﬀerentially expressed. However, even in experiments where
very many genes are changed, one will usually want to know
the most important ones; so what seems to be a limitation is
indeed a very useful feature. In addition, it is a conservative
assumption as it tends to restrict the number of genes that will
be called signiﬁcantly changed.
We compare the performance of our method on three bio-
logical data sets with the signiﬁcance analysis of microarrays,
SAM [8]. We chose SAM as our benchmark, because of its
reported performance in comparative studies and because it is
a prototypical example of a class of current techniques with
similar concept [2,9,10]. According to the Science Citation
Index, SAM is currently the most popular method for diﬀer-
ential gene expression analysis. Here, we show that our method
yields more sensitive and reliable results than SAM when
evaluated by a variety of criteria.2. Materials and methods
2.1. Analytical techniques
The RP method. Our algorithm for identifying diﬀerentially ex-
pressed genes is based on the approach that a biologist might make
when analyzing the data manually: Consider a simple two-color mi-
croarray experiment comparing mRNA levels under conditions A and
B on one slide. After the ﬁrst experiment, the biologist will know
which genes are most highly up- or downregulated in condition A vs.
B, but, as the data are very noisy, one would not rely too much on
these results. However, if the same gene shows up at the top of the
list in a replicate experiment, one’s conﬁdence will increase and after
consistent results in further replicates may reach virtual certainty. For
an experiment examining n genes in k replicates, one might argue that
the probability for a certain gene to be at the top of each list (rank 1)
is exactly 1=nk if the lists were entirely random. Put diﬀerently, it is
extremely unlikely to observe a single gene at the top position of all
replicates if none of the genes were diﬀerentially expressed, i.e., if all
null hypotheses were true. More generally, for each gene g in k
replicates i, each examining ni genes, one can calculate the
corresponding combined probability as a rank product RPupg ¼Qk
i¼1ðrupi;g=niÞ, where rupi;g is the position of gene g in the list of genes in
the ith replicate sorted by decreasing FC, i.e. rup ¼ 1 for the most
strongly upregulated gene, etc. Analogously, RPdowng is calculated
from the list of genes sorted by increasing FC, i.e. rdown ¼ 1 for themost strongly downregulated gene. Note that when ni ¼ n for all
replicates, one can alternatively use the geometric mean rank
rupg ¼ ð
Qk
i¼1 r
up
i;g Þ1=k , without losing any information. These RP values
(or r values) can then be used to sort the genes according to the
likelihood of observing them so high on the lists of diﬀerentially
expressed genes just by chance. In many cases, this will already be
suﬃcient: Genes with the smallest RP values are the most interesting
candidates and the biologist can then select some of them for further
study. This method is suﬃciently straightforward to be implemented
manually in Excel for a typical number of replicates (see Supple-
mentary Material).
For single-channel arrays, e.g., Aﬀymetrix GeneChip arrays, the
RP values are calculated over all possible pairwise comparisons. To
correct for the fact that the pairwise comparisons between samples are
not independent, the signiﬁcance analysis has to be adjusted as de-
scribed below.
Determination of signiﬁcance levels. Usually, it will be interesting to
know how signiﬁcant the changes are and how many of the selected
genes are likely to be truly diﬀerentially expressed. Consider a micro-
array experiment with two replicates (A and B), each examining n
genes. In that case, the RP for a certain gene g will be
RPg ¼ ðrankreplicate Ag =nÞ  ðrankreplicate Bg =nÞ. This can be interpreted
as a p-value, as it describes the probability of observing gene g at a
certain rank ðrankreplicate Ag Þ or better in the ﬁrst replicate and at an-
other rank ðrankreplicate Bg Þ or better in the second replicate. Note that
this interpretation is valid when all ranks are equally likely, which is
the case when the replicates are independent, genes have equal variance
and none of them are diﬀerentially expressed. These are exactly the
assumptions of our method as described. The reason for why this p-
value (¼RP value) cannot be used directly to assess the signiﬁcance of
an observed expression change is simple: We are not interested in the
probability that a gene shows a certain expression pattern, but in the
combined probability, p0, of all expression patterns that are as unlikely.
In simple cases, i.e., when the number of genes is small, this probability
can be directly calculated from the RP values. For example, in an
experiment with two replicates and three genes, if a gene g is observed
at rank 2 in replicate A and in rank 1 in replicate B, its RP value will be
RP ¼ ð2=3Þ  ð1=3Þ ¼ 2=9. The same RP value can be obtained if the
gene has rank 1 in the ﬁrst and rank 2 in the second replicate. Thus, the
combined probability, which we are interested in, is p0 ¼ 2RP ¼ 4=9.
In general, for k replicates and n genes, this probability can be calcu-
lated by multiplying the RP value by a factor F, where F is the number
of possible products of k numbers smaller than n that are equal to the
numerator of the RP value. In the above example, F equals 2 because
there are two such products (1 2 and 2 1). F depends on the
number and type of prime factors of the numerator of the RP value,
thus it is not easy to calculate in general.
Fortunately, a simple permutation-based estimation procedure
provides a very convenient way to determine how likely it is to observe
a given RP value or better in a random experiment, thus converting
from the RP value to an E value in analogy to the BLAST results
familiar to molecular biologists [11]. In the test cases described below,
we approximate the RP value distribution in each case by calculating
the RP values for, say, 100 random ‘‘experiments’’ with the same
number of replicates and ‘‘genes’’ as the real experiment. Each random
experiment consists of k random permutations of the numbers 1; . . . ; n
and for these the RP values are calculated as described above. We can
then just count how many simulated RP values smaller than or equal
to a given experimental RP value occur in the 100 random experiments
(x(RP)) and calculate the average expected value EðRPÞ  xðRPÞ=100.
Large numbers of random experiments will provide better estimates of
the E value. At the same time, the procedure to convert RP values to E
values automatically addresses the multiple testing problem associated
with the simultaneous analysis of thousands of genes in the same
experiment.
Subsequently, for each gene g, one can also calculate a conservative
estimate of the percentage of false-positives (PFP) if this gene (and all
genes with RP values smaller than this cutoﬀ) would be considered as
signiﬁcantly diﬀerentially expressed: qg ¼ EðRPgÞ=rankðgÞ. Here,
rank(g) denotes the position of gene g in a list of all genes sorted by
increasing RP value, i.e., it is the number of genes accepted as signif-
icantly regulated. This estimates the false discovery rate [12] and
provides a ﬂexible way to assign a signiﬁcance level to each gene. One
can now decide how large a PFP would be acceptable and extend the
list of accepted genes up to the gene with this qg value.
Table 1
Comparison of the number of ‘‘spots’’ identiﬁed as diﬀerentially ex-
pressed in potassium-starved A. thaliana seedlings
Total spots identiﬁed
at FDR 10%
Number
of genes
Duplicated
detectionsa
SAM
Shoots 0 0 0
Roots 68 55 24 (35%)
Roots plus
shoots
65 53 22 (34%)
RP
Shoots 32 21 22 (69%)
Roots 36 24 24 (67%)
Roots plus 78 52 49 (63%)
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the false discovery rate in SAM, assumes the independence of genes
and may yield underestimates when expression measurements of many
of the top genes on an array are dependent, e.g., because of cross-
hybridization. However, this will not aﬀect the sorting of genes but
only the decision of where to place a signiﬁcance cutoﬀ.
For single-channel arrays, the random experiment has to be slightly
modiﬁed. Instead of permuting the ranks for each replicate, we per-
form permutations of the expression values for each array and then
calculate the corresponding fold-changes for all pairwise comparisons.
This replicates the dependency structure of the original data. These
fold-changes are then used to calculate RP values as described above.
Normalization and pre-processing. For the analysis by SAM and by
the RP method, exactly the same normalized data were used. For
consistency, all data (see below) were subjected to quantile normali-
zation [13]. To normalize the measurement variance at diﬀerent in-
tensities, we used variants of the started-log procedure [5], i.e., for the
A. thaliana data we used the intensity values directly, without back-
ground subtraction, for the leukemia data, we added a constant to all
measurements, so that the smallest value becomes one, and for the
ApoAI/SR-BI data we added a constant of 7680, which we estimated
to minimize the deviation from constant variance using the method
outlined in [5]. We intentionally used these simpliﬁed techniques to
avoid introducing particular assumptions in the normalization process
that would bias the performance of the detection algorithms in the next
step. For the same reason, no ﬁltering for low-intensity or low-quality
signals was done.
SAM. The implementation of the SAM algorithm [8] was obtained
as a Microsoft Excel add-in from http://www-stat.stanford.edu/~tibs/
SAM/.
2.2. Data sets
Arabidopsis thaliana potassium starvation. This data set from our
laboratory examines plant seedlings that were germinated and grown
in the absence of the essential macro-nutrient potassium for 2 weeks
versus non-starved control samples of the same age and tissue. The
experiment consists of 3 two-color microarrays for shoots and 3 two-
color microarrays for roots. Each array contains 1250 non-blank
probes for genes encoding known and predicted transmembrane
transporters, as well as controls, all spotted in duplicate in two sub-
arrays as described in [14]. A detailed biological interpretation of these
data will be published elsewhere.
High-density lipoprotein (HDL)-deﬁcient mouse models. This study
examined gene expression in two mouse models with low levels of
HDL. Expression data for ApoAI knockout and SR-BI transgenic
mice [15,16] were obtained from http://www.stat.berkeley.edu/users/
terry/zarray/Html/matt.html. Each data set contains eight hybrid-
izations of Cy5 labeled mRNA from wild-type mouse liver and eight
hybridizations of Cy5 labeled mutant mouse mRNA, each hybrid-
ized against a pool of Cy3 labeled mRNA from the same eight wild-
type mice. A total of 6384 genes and controls were present on each
array.
Acute leukemia samples. Expression data for bone-marrow samples
from leukemia patients [17] were obtained from http://www-ge-
nome.wi.mit.edu/cgi-bin/cancer/datasets.cgi. The data set consists of
27 hybridizations of acute lymphoblastic leukemia (ALL) samples and
11 hybridizations of acute myeloid leukemia (AML) samples on Af-
fymetrix high-density oligonucleotide microarrays representing 7129
genes and controls.shoots
Total spots includedb
Fold-change
Shoots 32 22 20 (63%)
Roots 36 22 27 (75%)
Roots plus
shoots
78 54 53 (68%)
The number of spots that correspond to genes found in duplicate is
also shown. See text for details about the combined roots plus shoots
analysis. FDR false discovery rate.
aA few genes are represented by three or more spots.
b For the FC method, the number of genes included was chosen to be
the same as for RP. This corresponds to minimum fold-changes be-
tween 1.5-fold (roots + shoots, upregulated) and 2.1-fold (roots, up-
regulated).3. Results
The comparison of the performance of algorithms for the
detection of diﬀerentially expressed genes is hampered by the
diﬃculty of deciding on a ‘‘gold standard’’ experiment. For a
biological sample it is usually not known which genes are the
true positives, and simulated data or arrays that are
‘‘spiked’’ with known amounts of certain mRNAs are both
highly artiﬁcial and not necessarily representative of the
conditions encountered in real samples. Even the ‘‘veriﬁca-
tion’’ of microarray results by an alternative technique suchas quantitative RT-PCR is just replacing one error-prone
method by another. One might deﬁne a true positive gene as
one that is highly likely to be detected as diﬀerentially ex-
pressed each time the same experiment is repeated, and we
make use of this concept below. In addition, we use bio-
logical knowledge to assess the quality and consistency of the
results. As a benchmark for our RP approach, we used the
SAM [8], one representative of a class of current analytical
techniques that have all been shown to have quite similar
performance [2,4]. As in most analyses below the predicted
number of diﬀerentially expressed genes is small, SAM
should perform particularly well [2], In some cases, we also
included the results of an average-FC ranking of genes,
which despite its obvious shortcomings concerning the deﬁ-
nition of signiﬁcant changes performs quite well for many
biological data sets.
3.1. Arabidopsis thaliana potassium starvation
In the ﬁrst attempt to evaluate the consistency of our algo-
rithm, we made use of our A. thaliana membrane transporter
microarray [14], which is spotted in two identical subarrays
and thus contains an internal duplicate of each gene. We an-
alyzed the data for each duplicate spot independently, i.e., we
treated the two subarrays as if they contained diﬀerent genes.
Of course the measurements for the duplicate spots are highly
dependent, but we argue that if a true positive is a gene that
has an increased likelihood of being detected as diﬀerentially
expressed in any repetition of the experiment, then it should be
even more likely to be detected in two simultaneous subarrays.
A good algorithm would be one that consistently detects
diﬀerentially expressed genes in both duplicate spots.
The results are shown in Table 1. It can be seen that,
overall, SAM and RP detect about the same number of
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Fig. 1. Venn diagrams showing the genes identiﬁed as diﬀerentially
regulated by the three algorithms indicated, in potassium-starved
A. thaliana shoots (A), roots (B) and an analysis of both data sets
combined (C, see text for details). Genes that were identiﬁed in du-
plicate by at least one method are shown in bold. Genes that are
downregulated in the potassium-starved condition are marked by *.
Where available, genes are indicated by their gene names, predicted
and uncharacterized genes by arbitrary identiﬁers. Although SAM did
not detect signiﬁcantly changed genes in shoots, the top 22 genes found
by SAM are included for comparison.
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rate of 10%. The performance of RP is slightly more even, in
that it detects diﬀerentially expressed genes in shoots (where
SAM ﬁnds no signiﬁcant diﬀerences between the samples at
this cutoﬀ level) and also detects some downregulated genes.
The main diﬀerence is in the ‘‘duplicate recovery rate’’, i.e.,
the percentage of spots that are also identiﬁed as regulated in
their corresponding duplicate in the second subarray. In SAM
this rate is about 1/3, which means that about 20% of the
detected genes are found in duplicate. The corresponding rate
in RP is about twice as high, about 2/3, and a simple pen-
and-paper calculation shows that this means that about half
of the genes are found in duplicate. This result does not
change if it is corrected for the diﬀerent number of genes
detected as ‘‘signiﬁcantly changed’’ by the two methods. It can
also be seen that RP and FC perform very similarly – except
that FC is naturally not usable to delimit the length of the
results lists based on a signiﬁcance criterion. Instead, the
cutoﬀ from RP had to be used for this purpose to make the
comparison possible.
Fig. 1 shows a more detailed comparison of the results of
SAM, RP and a FC ranking. For the latter, the cutoﬀ was
selected in such a way that the resulting gene lists had the same
length as for RP. The same was done for SAM in the case of
shoots, as SAM did not detect signiﬁcantly changed genes at a
false discovery rate of 10% in that tissue. It can be seen that the
majority of genes that are detected by all three methods are
found in duplicate by at least one of them. This seems to
conﬁrm the idea that these genes are enriched for true posi-
tives. It is also striking that there is a large overlap between RP
and FC, which again contains a large number of genes detected
in duplicate. This good agreement was not necessarily ex-
pected, as the RP method requires a radical transformation of
the raw data and discards all information about the absolute
expression levels. It shows, however, that RP yields results that
agree well with the intuitive concept that interesting genes will
show the highest consistent changes.
On the other hand, the overlap between RP and SAM is
larger than between FC and SAM, which may be due to a
higher ‘‘robustness’’ of RP towards inconsistent changes, such
as single outliers. Some limits of the performance parameters
of SAM and RP may be estimated from the observed ‘‘du-
plicate recovery rate’’. If for the moment we assume that all
spots called ‘‘signiﬁcantly diﬀerent’’ in duplicate correspond
to true positives and those that are detected only once are
either all true positives (and should be detected twice) or all
false positives (and should not be detected at all), we can
estimate limits for the PFP and the percentage of false-neg-
atives (PFN) in these two extreme scenarios. In the case of
SAM (duplicate recovery rate about 1/3), either the
PFN P 40% (and the PFP P 0%) or the PFP P 66% (and
the PFN P 0%). For RP (where the duplicate recovery rate is
about 2/3), the corresponding limit values are PFN P 25%
(PFP P 0%) and PFP P 33% (PFN P 0%), respectively.
The true values are probably somewhere in-between, but in
any case RP seems to perform better than SAM in this
respect.
As a special challenge for the statistical tests, we not only
analyzed roots and shoots separately but also included a
joined analysis (roots plus shoots), which should detect
genes that are consistently changed in both tissues. In the
joined data, the measurement variance for each gene is
Table 2
Comparison of the top 20 diﬀerentially expressed genes in HDL-deﬁcient mouse models identiﬁed by RP and SAM
ID Rank product method ID SAM method
(A) Top 20 up-regulated genes in ApoAI k.o. (not signiﬁcant at a false detection rate of 6 20%)
1238x Similar to cytochrome c oxidase polypeptide I 1239x Similar to S-adenosylmethionine synthetase
1239x Similar to S-adenosylmethionine synthetase 5692 Olf-1
2939y Apolipoprotein A-II precursor 4418x Similar to fructose-bisphosphate aldolase B
4346 Hemoglobin b, pseudogene 1254x Est
4418x Similar to fructose-bisphosphate aldolase B
(human)
1238x Similar to cytochrome c oxidase polypeptide I
1248 417 Similar to cAMP-dependent protein kinase
major membrane substrate
3488 Procollagen, type IV, a1 6029
847 2929y Apolipoprotein C-I precursor
1222 Est 5540 Est
3386 MDB0087 4892 FGF12A
5986 Cy3RT 1235x Similar to cytochrome b
6136y Peroxisomal fatty acyl CoA oxidase 5043 Blank
809 Est 45
1254x Est 5100 Est
1242 3445 cDNA from an individual with schizophrenia
799 Cy3RT 2813 Est
1235x Similar to cytochrome b 5918 Ezrin
6008 862x Similar to cytochrome c oxidase polypeptide I
839 Similar to ATP synthase A chain 840
862x Similar to cytochrome c oxidase polypeptide I 5539 Est
(B) Top 20 down-regulated genes in ApoAI k.o.
2149 Apo AI 2537 Highly similar to apolipoprotein C-III precursor
540 Highly similar to apolipoprotein A-I precursor 2149 Apo AI
5356 Catechol O-methyltransferase 4139 Weakly similar to C-5 sterol desaturase
2537 Highly similar to apolipoprotein C-III precursor 5356 Catechol O-methyltransferase
4139 Weakly similar to C-5 sterol desaturase 1739 Apo CIII
1739 Apo CIII 1496 Est
1496 Est 540 Highly similar to apolipoprotein A-I precursor
563y Fatty acid-binding protein 4941 Similar to yeast sterol desaturase
3729y Moderately similar to fatty acid-binding protein 1652 Est
1337y Psoriasis-associated fatty acid binding protein 2107x Sox5
2091 ?? 2106x Pigment-epiththelium derived factor
2106x Pigment-epiththelium derived factor 2083 Unk homeo3
2538y Apolipoprotein B mRNA-editing component 1
(Apobec1)
1347 Transcription factor GATA-6
2323y Colony stimulating factor, macrophage 2165 Tumor necrosis factor
1736y 30 kDa adipocyte complement-related protein
Acrp30
2536y Retinol-binding protein II, cellular
4941 Similar to yeast sterol desaturase 2022 Similar to sarcoplasmic reticulum histidine-rich
calcium-binding
3709 ID-2 DNA binding protein inhibitor/extra
macrochaetae homolog1
2048
3346y Hormone-sensitive lipase 3623
2107x Sox5 3729y Moderately similar to fatty acid-binding protein
4530 Brain protein D3 2160y CTP: phosphocholine cytidylyl transferase
(C) Top 20 up-regulated genes in SR-BI transgenic
1581 SRB1 mouse PCR 1581 SRB1 mouse PCR
783 SRB1 mouse PCR 783 SRB1 mouse PCR
3261 Similar to glutathione S-transferase p class 3261 Similar to glutathione S-transferase p class
5312x Diﬀ. Ass. Prot. 13 kDa 5312x Diﬀ. Ass. Prot. 13 kDa
2287x Ubiquitin-conjugating enzyme E2H 3615x
2408 Similar to hemoglobin f chain (human) 3709x ID-2 DNA binding protein inhibitor/extra
macrochaetae homolog1
3 mSRB1 976 MDB0008
4921 Scavenger receptor class B type I (mSR-BI) 4966x MDB0211
4006 Similar to hemoglobin a chain 4003 Similar to hemoglobin b-1 chain
4815 Similar to hemoglobin b chain 2408 Similar to hemoglobin f chain
3709x ID-2 DNA binding protein inhibitor/extra
macrochaetae homolog1
5649 Similar to cytochrome c oxidase polypeptide II
421x Est 4006 Similar to hemoglobin a chain
3615x 4815 Similar to hemoglobin b chain
5203 b globin 936y Highly similar to fatty acid-binding protein
409 Est 421x Est
4013 4407 Est
471 Similar to hemoglobin a chain 2459 Similar to a-globin
4087 Unk 2287x Ubiquitin-conjugating enzyme E2H
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Table 2 (continued)
ID Rank product method ID SAM method
2459 Similar to a-globin 5923 Even skipped homeotic gene 2 homolog
4966x MDB0211 1293 IGF2R
(D) Top 20 down-regulated genes in SR-BI transgenic
4285x Capping protein a2 4755x Angiotensinogen
2854 Similar to human metallothionein-Ie gene 4629 MDB1406
4755x Angiotensinogen 5759y Long chain fatty acid CoA ligase
4866 est 2482x Myogenin-like
5676 tyk2 like 6135y Plasminogen activator inhibitor-2, macrophage
5243 est 2523y Macrophage colony stimulating factor I receptor
precursor
5914 est 4137 Highly similar to tubulin c-1 chain
1267y Similar to very low density lipoprotein receptor 1267y Similar to very low density lipoprotein receptor
4483 Unk homeo 2873x Ex312 (CTG4a)
2401 3120 Retinoblastoma 1
2482x Myogenin-like 4285x Capping protein a2
2873x Ex312 (CTG4a) 3134 Est
4527y Weakly similar to ﬁbrinogen a and a-E chain
precursors
2543y TGF b receptor-II
5759 Long chain fatty acid CoA ligase 3154 Est
1075x Growth factor receptor bound protein 2 2856 Est
5262 Est 1075x Growth factor receptor bound protein 2
5325y Retinol binding protein (RBP) 4133 Neuroﬁlament, heavy polypeptide
4934y HMG CoA synthase 1745 Highly similar to cytochrome c oxidase
polypeptide VA precursor
2127 Highly similar to cytochrome P450 IIC24 4482 Apterous homolog 2
867y Similar to diazepam-binding inhibitor 1206
(E)
Summary RP SAM Fold-change
Blanks/
Controls
10 8 6
Genes
identiﬁed
by t-test ()
19 16 20
Additional
lipid-related
genes (y)
15 10 16
Genes reported as diﬀerentially expressed by Dudoit et al. [15] based on a strict t-test are marked by a . Additional lipid-related genes are marked by
a y, further genes shared by SAM and RP are marked by a x. Table 2E shows a summary, comparing the number of blanks/controls identiﬁed by each
method (probable false positives), the number of genes also identiﬁed by the t-statistics (probable true positives) and further lipid-related genes
(possible true positives). The ID numbers are arbitrary identiﬁers.
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niﬁcant changes more diﬃcult. In fact, using the criteria
outlined above the advantages of RP over both SAM and
FC are particularly obvious in this analysis (Fig. 1C),
probably because the relative fold-changes represented by
ranks are more robust than the absolute fold-changes con-
sidered by SAM and FC.3.2. HDL-deﬁcient mouse models
In the second analysis, we compare the performance of SAM
and RP on expression data from mouse models with low levels
of HDL. In this case, the underlying biology of the experiment
is well understood and can be used to assess the quality of the
algorithms. Due to the more complex experimental design of
that study [16], which uses a common reference instead of
paired hybridizations between wild-type and mutant samples,
the RP method had to be slightly modiﬁed. We calculated the
RP values independently for the comparison of wild type vs.
reference pool ðRPwtÞ and for mutant vs. reference pool
ðRPmutÞ and then used the ratio RPmut=RPwt to sort the genes,
thus eliminating genes that are changed to the same extent and
direction in both mutant and wild-type samples relative to thereference pool. Note that as always this procedure is per-
formed independently for up- and downregulation. The results
are shown in Table 2.
All methods agree that there are no signiﬁcantly upregulated
genes in the ApoAI knockout, conﬁrming that the E value as
calculated for RP performs comparable to the SAM (the top
20 genes that are shown in Table 2A were not signiﬁcant at a
FDR 6 20%). Both SAM and RP ﬁnd the same genes that
have already been reported as changed by a strict t-test pro-
cedure [15], RP ﬁnds slightly more replicate probes for these
genes among its list of highest scoring genes. More signiﬁcant,
however, is the detection rate of lipid-related genes among the
top 20 hits for the two methods, as the biology of the mouse
models indicates that such genes are most likely to be true
positives [16]. RP includes about 50% more genes of this class
among its top 20 hits. This is particularly striking in the case of
the ApoAI knockout, where three replicate spots for fatty-acid
binding protein (FABP) receive very low (i.e., signiﬁcant) RP
values, while only one of them is included among the top 20
hits reported by SAM. The fact that three replicate spots for
FABP are assigned consistently low RP values indicates that
this gene is indeed a true positive and should not be missed by
a reliable detection algorithm. The same is probably true for
Table 3
Comparison of the performance of RP and SAM on subsets of the leukemia data set of Golub et al. [17]
SAM
(all data)
RP
(all data)
RP1 RP2 RP3 SAM1 SAM2 SAM3
Top 25 up-regulated genes
Zyxin 1 1 15 37 15 56 15 70
FAH fumarylacetoacetate 2 3 88 61 104 153 1 75
Leukotriene C4 synthase (LTC4S) gene 3 12 17 67 45 2 84 15
LYN V-yes-1 Yamaguchi sarcoma viral-related
oncogene homolog
4 4 43 1691 39 107 1555 38
CTSD cathepsin D (lysosomal aspartyl protease) 5 7 2 92 14 29 383 236
FTL ferritin, light polypeptide 6 19 4997 3 4 1107 17 154
APLP2 amyloid b (A4) precursor-like protein 2 7 11 115 157 32 414 692 132
DF D component of complement (adipsin) 8 13 566 658 47 426 1067 1
Induced myeloid leukemia cell diﬀerentiation
protein MCL1
9 21 959 234 20 691 357 48
CST3 cystatin C (amyloid angiopathy and cere-
bral hemorrhage)
10 2 26 507 1 971 1256 31
PRG1 proteoglycan 1, secretory granule 11 59 1 5495 6 14 2241 5
LEPR leptin receptor 12 5 51 272 175 143 1126 430
CD33 CD33 antigen (diﬀerentiation antigen) 13 14 42 2050 66 53 2288 20
PPGB protective protein for b-galactosidase
(galactosialidosis)
14 29 13 2555 41 1 1941 114
Phosphotyrosine independent ligand p62 for the
Lck SH2 domain mRNA
15 67 90 9 1496 298 16 732
ATP6C vacuolar H+ ATPase proton channel
subunit
16 23 852 23 30 693 69 50
Interleukin-8 precursor 17 49 3057 1 12 832 38 34
Interleukin 8 (IL8) gene 18 44 3015 4 35 802 22 121
ITGAX integrin, a X (antigen CD11C (p150),
a polypeptide)
19 16 36 136 1749 4 652 1595
GB DEF ¼ homeodomain protein HoxA9
mRNA
20 17 1154 119 93 1320 35 120
ME491 gene extracted from H. sapiens gene for
Me491/CD63 antigen
21 6 60 2839 28 225 1647 216
Liver mRNA for interferon-c inducing factor
(IGIF)
22 73 199 1389 241 39 1580 26
P58 natural killer cell receptor precursor mRNA,
clone cl-39
23 20 14 4711 11 3549 3853 1595
PFC properdin P factor, complement 24 45 37 5060 78 135 3068 18
Peptidyl-prolyl cis–trans isomerase,
mitochondrial precursor
25 42 638 219 181 890 175 361
Top 25 downregulated genes
ALDR1 aldehyde reductase 1 (low Km aldose
reductase)
1 10 81 147 120 154 282 342
Retinoblastoma binding protein P48 2 6 36 58 37 30 70 499
Macmarcks 3 2 10 152 6 72 623 1
C-myb gene extracted from human (c-myb) gene,
complete primary cds, and ﬁve complete
Alternatively spliced cds 4 1 452 5 2 445 63 85
ACTN2 actinin a2 5 71 611 1631 203 864 1779 621
Oncoprotein 18 (Op18) gene 6 42 620 11 48 691 94 344
IEFSSP 9502 mRNA 7 34 681 244 192 776 217 289
HNRPG heterogeneous nuclear ribonucleo-
protein G
8 31 92 1076 104 103 1091 837
Proteasome i Chain 9 8 11 3 20 276 4 427
MYL1 myosin light chain (alkali) 10 24 128 256 750 10 183 1641
GCND3 cyclin D3 11 4 8 10 1 47 121 15
ACADM acyl-coenzyme A dehydrogenase, C-4
to C-12 straight chain
12 12 70 134 53 76 343 143
Inducible protein mRNA 13 9 44 126 737 214 790 446
Stimulator of TAR RNA binding (SRB) mRNA 14 11 132 155 140 285 602 677
Estrogen sulfotransferase mRNA 15 139 2120 2556 12 3076 229 136
Ras GTPase-activating-like protein (IQGAP1)
mRNA
16 37 570 42 113 665 108 316
Pulmonary surfactant-associated protein a
precursor
17 5 195 61 32 3076 2531 274
HMG1 high-mobility group (non-histone
chromosomal) protein 1
18 148 4745 691 8 1237 804 199
Transcription factor (CBFB) mRNA, 30 end 19 47 96 103 1768 196 262 1451
SRP9 signal recognition particle 9 kDa protein 20 22 32 105 40 39 289 1567
MCM3 minichromosome maintenance deﬁcient
(S. cerevisiae) 3
21 27 131 487 282 194 707 1497
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Table 3 (continued)
SAM
(all data)
RP
(all data)
RP1 RP2 RP3 SAM1 SAM2 SAM3
Heat shock protein, 70 kDa (Gb:Y00371) 22 39 55 89 3171 8 429 2959
Interferon c up-regulated 1-5111 protein
precursor
23 50 25 26 2437 27 86 3539
DHPS deoxyhypusine synthase 24 53 583 196 429 577 85 645
Butyrophilin (BTF5) mRNA 25 29 166 113 410 234 120 146
Average rank 13 24.08 555.62 737.32 313.56 536.52 721.8 506.66
Median rank 13 20.5 91 141.5 47.5 219.5 316 207.5
Median rank(RP): 99.5 Median rank(SAM): 235
The top 25 up- and downregulated genes identiﬁed by SAM of the complete data set are shown. The ﬁrst two columns show the ranks
assigned to each of these 50 genes by SAM and RP in their analysis of the complete data set. The next columns show the ranks assigned by
RP (RP1–RP3) and SAM (SAM1–SAM3) in their analysis of random subsets of the data, each consisting of three lymphoblastic and three
myeloid samples. The average and median rank assigned for each subset and the median for all three subsets is indicated at the bottom of the
table.
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Fig. 2. Boxplot showing the dependence of RP and SAM results on the
number of replicates. The boxes extend from the ﬁrst to the third
quartile, with a notch at the median. The ‘‘whiskers’’ extend to 1.5
the interquartile range but not further than the data range. If the
central notches do not overlap, the medians are signiﬁcantly diﬀerent
at the 5% level. SAM requires replication, therefore no SAM results
are shown for a subset size of 2 (i.e., an unreplicated experiment). See
text for details. RP ﬁlled symbols; SAM open symbols.
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relevant for an HDL-deﬁcient mouse model [18,19], yet are
missed by SAM and the classical t-test (see Table 2E for a
summary).
As in the A. thaliana example, FC and RP show a very
similar performance. This demonstrates that RP can indeed
serve as a reasonable replacement of FC, while at the same
time overcoming its essential limitations (such as arbitrary
threshold and lack of statistical interpretability).
3.3. Acute leukemia samples
In both the A. thaliana data and the HDL-deﬁcient mouse
mutant data, our results might be explained by a lower false-
negative rate in the RP method, which might come at the cost
of a corresponding increase in the false-positive rate, although
there is no indication that the false-positive rate of RP is
particularly high. In the third analysis, we used an entirely
diﬀerent comparison to avoid this problem.
The leukemia data set [17] contains a large number of high-
quality replicates. We argue, in agreement with Broberg [4],
that an analysis of the complete data set should yield a reliable
approximation to a ‘‘gold standard’’ set of true positives. A
good algorithm should then give good ranks to these true
positive genes even when using only a small fraction of the
complete data set [4]. We thus chose three random subsets of
the data, each consisting of three ALL and three AML samples
and analyzed them by SAM and RP. As RP works with paired
data, we used all nine possible pairwise combinations of the
3+ 3 data sets as input for that method. For each subset, we
determined the rank assigned to the top 25 up- and down-
regulated genes determined by a SAM analysis of the complete
data set (note that SAM gets a head start in this respect). The
results are shown in Table 3. It can be seen that SAM and RP
agree quite well in their analysis of the complete data. How-
ever, in the analysis of the subsets, RP performs much better:
The median rank assigned to the ‘‘gold standard’’ genes is
about twice as good as that assigned by SAM. This diﬀerence
is much more striking than those observed by Broberg [4] in his
comparison of SAM, a Bayesian approach [20] and his samroc
algorithm using a similar approach. This conﬁrms once more
the sensitivity and reliability of the RP method.
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The large number of hybridizations in the leukemia data set
makes it possible to check how SAM and RP perform de-
pending on the number of replicates used for the analysis
(Fig. 2). As before, we use the complete data set as a substitute
for a ‘‘gold standard’’. We selected the top 25 up- and down-
regulated genes by either SAM or RP of the complete data.
Then, we determined the rank of these genes in random subsets
of the data (each consisting of equal numbers of myeloid and
lymphoblastic samples). The median rank of the 25 genes
converges to 13 when an increasing fraction of the total data is
used. As can be seen in Fig. 2, RP converges much faster on its
ﬁnal result than SAM. For example, on average a simple du-
plicate experiment (subset size¼ 4 arrays) analyzed by RP is
equivalent to a quadruplicate experiment (subset size¼ 8 ar-
rays) analyzed by SAM.4. Discussion
We have presented evidence that the simple if unconven-
tional RP method outperforms a sophisticated statistical
technique (SAM) as assessed by a variety of criteria. As the
assumptions of SAM and other modern techniques for the
detection of diﬀerentially regulated genes are closely related [2]
and their performance in comparative studies is quite similar,
we predict that this ﬁnding is not restricted to SAM but is of
more general relevance.
What can explain the success of RP? Several factors
probably contribute. First, RP makes only relatively weak
assumption about the data, i.e., it expects about equal vari-
ance for all genes. This requirement is biologically reasonable
and is easily met by a number of recently developed nor-
malization techniques [5–7], the simplest of which (started-
log [5]) we used in the present study. In contrast, even the
weak assumptions made by other non-parametric statistics
may be too strong for microarray data. Second, our results
seem to conﬁrm the biological intuition that signiﬁcant gene
regulation is almost a switch-like process, so that relevant
changes should always be large, while small changes may
have statistical but rarely biological signiﬁcance. Previously,
the strong disagreement between, e.g., t-test results and
simple FC lists, has been used as an argument for the su-
periority of the former. In contrast, we argue that the sur-
prisingly good agreement between RP and the average-FC
approach increases our conﬁdence in the novel method. The
diﬀerence between RP and FC criteria is nonetheless very
important: not only is RP more robust against outliers, it
also provides a simple and straightforward procedure to
determine the signiﬁcance of an observed change. The
A. thaliana data show that the signiﬁcance threshold deter-
mined in this way can correspond to widely diﬀerent absolute
fold-changes.
The strong performance of RP with very small data sets
(Fig. 2) indicates that another advantage of RP is its stability
against increasing levels of uncertainty in the variance esti-
mation that seriously hamper all variants of the t-test, such as
SAM. RP does not rely on estimating the measurement
variance for each single gene and thus is particularly useful
when this estimate becomes unreliable due to a low number
of replicates. But as the analysis of the Leukemia data setshows, even for 11 replicates RP can outperform SAM
signiﬁcantly.
It is obvious that the RP method has other advantages
over previous statistical techniques, not the least being the
simplicity of its underlying reasoning. Another advantage is
the ease with which results from various experimental plat-
forms can be combined in one analysis. As long as the results
are expressible as ranked lists, it does not matter whether
they are produced by two-color cDNA arrays, ﬁlter arrays,
or Aﬀymetrix oligo chips. It can also be applied to proteome
and metabolome studies where ranked lists of changed pro-
teins or metabolites are produced by 2D-gels or mass spec-
trometry. The method also provides suitable input data for
automated microarray interpretation tools such as iterative
Group Analysis [21]. And of course the RP method could
have wider applications as a new non-parametric test in
the statistical analysis of diverse rankable data outside of
biology.
Rank products provide a powerful new test statistics for
deﬁning diﬀerentially expressed genes in microarray experi-
ments. Because of its non-parametric nature, it requires only a
few well-justiﬁed assumptions about the data. In contrast to
previous techniques, in particular t-test-based statistics such as
SAM, RP does not depend on an estimate of the gene-speciﬁc
measurement variance and is therefore particularly powerful
when only a small number of replicates are available, as is
currently the case in the majority of biological studies. In such
cases, it can cut the number of required hybridizations in half
(Fig. 2), thus resulting in considerable savings of both time and
money (or rather expanding the range of microarray applica-
tions to areas where more replicates are not available for
various reasons). Our analysis also demonstrates the usefulness
of real data sets, in contrast to simulated data, for the assess-
ment of algorithm performance in microarray analysis. The RP
method has been successfully implemented and is now used as
the standard method for microarray data analysis at the Sir
Henry Wellcome Functional Genomics Facility at University
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